On the development of new biocatalytic processes for practical pharmaceutical synthesis

Current Opinion in Chemical Biology

Volumn 17, Issue 2, 2013, Pages 284-292

  Huisman, Gjalt W ^a   Collier, Steven J ^b  

^a R and D Project Development and Management   (United States)

^b Codexis Laboratories Singapore Pte Ltd ^*  (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOTRANSFERASE; HYDROLASE; OXIDOREDUCTASE;

BIOCATALYSIS; HYDROLYSIS; NONHUMAN; REVIEW; TRANSAMINATION;

BIOCATALYSIS; BIOTECHNOLOGY; CHEMISTRY, PHARMACEUTICAL; ENZYMES; GREEN CHEMISTRY TECHNOLOGY; PHARMACEUTICAL PREPARATIONS;

APIS;

EID: 84876710917     PISSN: 13675931     EISSN: 18790402     Source Type: Journal    
DOI: 10.1016/j.cbpa.2013.01.017     Document Type: Review

References (51)

1. Bornscheuer U.T., Huisman G.W., Kazlauskas R.J., Lutz S., Moore J., Robins K. Engineering the third wave of biocatalysis. Nature 2012, 485:185-194.
2. Dach R., Song J.J., Roschangar F., Samstag W., Senanayake C.H. The eight criteria defining a good chemical manufacturing process. Org Process Res Dev 15 2012, 10.1021/op300144g.
3. Huisman G.W., Liang J., Krebber A. Practical chiral alcohol manufacture using ketoreductases. Curr Opin Chem Biol 2010, 14:122-129.
4. Wisdom RA, Lee CS, Brown RC: Microorganism, Lactamase Enzyme Obtained Therefrom and Their Use. US 6,423,522; 2002.
5. Martinez C.A., Hu S., Dumond Y., Tao J., Kelleher P., Tully L. Development of a chemoenzymatic manufacturing process for pregabalin. Org Process Res Dev 2008, 12:392-398.
6. Busto E., Gotor-Fernandez V., Gotor V. Asymmetric chemoenzymatic synthesis of ramatroban using lipases and oxidoreductuases. J Org Chem 2012, 77:4842-4848.
7. Hayes S.T., Assaf G., Checksfield G., Cheung C., Critcher D., Harris L., Howard R., Mathew S., Regius C., Scotney G., Scott A. Commercial synthesis of (S,S)-reboxetine succinate: a journey to find the cheapest commercial chemistry for manufacture. Org Process Res Dev 2011, 15:1305-2131.
8. Truppo M.D., Hughes G. Development of an improved immobilized CAL-B for the enzymatic resolution of a key intermediate to odanacatib. Org Process Res Dev 2011, 15:1033-1035.
9. Hummel W. Enzyme-catalyzed synthesis of optically pure R(+)-phenylethanol. Biotechnol Lett 1990, 12:403-408.
10. Hummel W. Reduction of acetophenone to R(+)-phenylethanol by a new alcohol dehydrogenase from Lactobacillus kefir. Appl Microbiol Biotechnol 1990, 34:15-19.
11. Liang J., Lalonde J., Borup B., Mitchell V., Mundorff E., Trinh N., Kochrekar D.A., Cherat R.N., Pai G.G. Development of a biocatalytic process as an alternative to the (-)-DIP-Cl-mediated asymmetric reduction of a key intermediate of montelukast. Org Process Res Dev 2010, 14:193-198.
12. Bechtold M., Brenna E., Femmer C., Gatti F.G., Panke S., Parmeggiani F., Sacchetti A. Biotechnological development of a practical synthesis of ethyl (S)-2-ethoxy-3-(p-methoxyphenyl)propanoate (EEHP): over 100-fold productivity increase from yeast whole cells to recombinant isolated enzymes. Org Process Res Dev 2012, 16:269-276.
13. Constable D.J.C., Dunn P.J., Hayler J.D., Humphrey G.R., Leazer J.L., Linderman R.J., Lorenz K., Manley J., Pearlman B.A., Wells A., et al. Key green chemistry research areas-a perspective from pharmaceutical manufacturers. Green Chem 2007, 9:411-420.
14. Matcham G.W., Bowen A.R. Biocatalysis for chiral intermediates: meeting commercial and technical challenges. Chim Oggi 1996, 14:20-24.
15. Shin J.S., Kim B.G. Asymmetric synthesis of chiral amines with omega-transaminase. Biotechnol Bioeng 1999, 65:206-211.
16. Tufvesson P., Lima-Ramos J., Jensen J.S., Al-Haque N., Neto W., Woodley J.M. Process considerations for the asymmetric synthesis of chiral amines using transaminases. Biotechnol Bioeng 2011, 108:1479-1493.
17. Hohne M., Schatzle S., Jochens H., Robins K., Bornscheuer U.T. Rational assignment of key motifs for function guides in silico enzyme identification. Nat Chem Biol 2010, 6:807-813.
18. Shin J.S., Kim B.G. Transaminase-catalyzed asymmetric synthesis of l-2-aminobutyric acid from achiral reactants. Biotechnol Lett 2009, 31:1595-1599.
19. Savile C.K., Janey J.M., Mundorff E.C., Moore J.C., Tam S., Jarvis W.R., Colbeck J.C., Krebber A., Fleitz F.J., Brands J., et al. Biocatalytic asymmetric synthesis of chiral amines from ketones applied to sitagliptin manufacture. Science 2010, 329:305-309.
20. Truppo M.D., Strotman H., Hughes G. Development of an immobilized transaminase capable of operating in organic solvent. ChemCatChem 2012, 4:1071-1074.
21. Molinaro C., Bulger P.G., Lee E.E., Kosjek B., Lau S., Gauvreau D., Howard M.E., Wallace D.J., O'Shea P.D. CRTH2 antagonist MK-7246: a synthetic evolution from discovery through development. J Org Chem 2012, 77:2299-2309.
22. Mangion I.K., Sherry B.D., Yin J., Fleitz F.J. Enantioselective synthesis of a dual orexin receptor antagonist. Org Lett 2012, 14:3458-3461.
23. Austad B, Bahadoor A, Belani JD, Janardanannair S, Johannes CW, Keaney GF, Lo CK, Wallerstein SL: Enzymatic Transamination of Cylcopamine Analogs. WO2011017551.
24. Cabirol FL, Gohel A, Collier SJ, Liang J, Mock M, Mundorff E, Novick S, Limanto J, Smith D, Beutner G, et al.: Biocatalysts and Methods for the Synthesis of (1R,2R)-2-(3,4-Dimethoxyphenethoxy)cylohexanamine. WO2012024104.
25. Alexeeva M., Enright A., Dawson M.J., Mahmoudian M., Turner N.J. Deracemization of alpha-methylbenzylamine using an enzyme obtained by in vitro evolution. Angew Chem Int Ed 2002, 41:3177-3180.
26. Koehler V., Bailey K.R., Znabet A., Raftery J., Helliwell M., Turner N.J. Enantioselective biocatalytic oxidative desymmetrization of substituted pyrrolidines. Angew Chem Int Ed 2010, 49:2182-2184.
27. Znabet A., Polak M.M., Janssen E., Kanter de F.J.J., Turner N.J., Orru R.V.A., Ruijter E. A highly efficient synthesis of telaprevir by strategic use of biocatalysis and multicomponent reactions. Chem Commun 2010, 46:7918-7920.
28. Li T., Liang J., Ambrogelly A., Brennan T., Gloor G., Huisman G.W., Lalonde J., Lekhal A., Mijts B., Muley S., et al. An efficient chemoenzymatic process for manufacture of the boceprevir bicyclic [3.1.0] proline intermediate based on amine oxidase-catalyzed desymmetrization. J Am Chem Soc 2012, 134:6467-6472.
29. Stewart J.D., Reed K.W., Zhu J., Chen G., Kayser M.M. A " Designer Yeast" that catalyzes the kinetic resolutions of 2-alkyl substituted cyclohexanones by enantioselective Baeyer-Villiger oxidations. J Org Chem 1996, 61:7652-7653.
30. Reetz M.T., Wu S. Laboratory evolution of robust and enantioselective Baeyer-Villiger monooxygenases for asymmetric catalysis. J Am Chem Soc 2009, 131:15424-15432.
31. Bong YK, Clay MD, Collier SJ, Mijts B, Vogel M, Zhang X, Zhu J, Nazor J, Smith D, Song S: Synthesis of Prazole Compounds. WO/2011/071982.
32. Ang EL, Clay MD, Behrouzian B, Eberhard E, Collier SJ, Fu Fan J, Smith D, Song S, Alvizo O, Widegren M, et al.: Biocatalysts and Methods for the Synthesis of Armodafinil. WO2012078800.
33. van den Wijngaard A.J., Reuvekamp P.T., Janssen D.B. Purification and characterization of haloalcohol dehalogenase from Arthrobacter sp. strain AD2. J Bacteriol 1991, 173:124-129.
34. Ma S.K., Gruber J., Davis C., Newman L., Gray D., Wang A., Grate J., Huisman G.W., Sheldon R.A. A green-by-design biocatalytic process for atorvastatin intermediate. Green Chem 2010, 12:81-86.
35. Fox R.J., Davis S.C., Mundorff E.C., Newman L.M., Gavrilovic V., Ma S.K., Chung L.M., Ching C., Tam S., Muley S., et al. Improving catalytic function by ProSAR-driven enzyme evolution. Nat Biotechnol 2007, 25:338-344.
36. Brovetto M., Gamenara D., Saenz Mendez P., Seoane G.A. CC bond-forming lyases in organic synthesis. Chem Rev 2011, 111:4346-4403.
37. Jennewein S., Schürmann M., Wolberg M., Hilker I., Luiten R., Wubbolts M., Mink D. Directed evolution of an industrial biocatalyst: 2-deoxy-d-ribose 5-phosphate aldolase. Biotechnol J 2006, 1:537-548.
38. Bauer DW, O'Nell PM, Watson TJ, Hu S: Process for Preparing Chiral Compounds. US20110118476.
39. Casar Z, Mesar T, Kopitar G, Mrak P, Oslaj M: Synthesis of Statins. US20120196333.
40. Greenberg W, Burk MJ, Varvak A, Wong K: Chemoenzymatic Methods for the Synthesis of Statins and Statin Intermediates. US8148324.
41. Xie X., Watanabe K., Wojcicki W.A., Wang C.C.C., Tang Y. Biosynthesis of lovastatin analogs with a broadly specific acyltransferase. Chem Biol 2006, 13:1161-1169.
42. Gilson L, Collier SJ, Sukumaran J, Yeo WL, Alviso O, Teo EL, Wilson R, Xu J: Variant LovD polypeptides and Their Uses. WO2011041231.
43. Collier SJ, Teo EL, Sukumaran J, Wilson RJ, Xu J: Improved Lov-D Acyltransferase Mediated Acylation. WO2011041233.
44. Ruff B.M., Bräse S., O'Connor S.E. Biocatalytic production of tetrahydroisoquinolines. Tetrahedron Lett 2012, 53:1071-1074.
45. Zandvoort E., Geertsema E.M., Baas B.-J., Quax W.J., Poelarends G.J. Bridging between organocatalysis and biocatalysis: asymmetric addition of acetaldehyde to b-nitrostyrenes catalyzed by a promiscuous proline-based tautomerase. Angew Chem Int Ed 2012, 51:1240-1243.
46. Jin J., Oskam P.C., Karmee S.K., Straathof A.J.J., Hanefeld U. MhyADH catalysed Michael addition of water and in situ oxidation. Chem Commun 2010, 46:8588-8590.
47. Jing Q., Kazlauskas R.J. Regioselective hydroformylation of styrene using rhodium substituted carbonic anyhdrase. ChemCatChem 2010, 2:953.
48. Hyster T.K., Knorr L., Ward T.R., Rovis T. Biotinylated Rh(III) complexes in engineered streptavidin for accelerated asymmetric CH activation. Science 2012, 338:500.
49. van Pelt S., Teeuwen R.L.M., Janssen M.H.A., Sheldon R.A., Dunn P.J., Howard R.M., Kumar R., Marti{dotless}nez I., Wong J.W. Pseudomonas stutzeri lipase: a useful biocatalyst for aminolysis reactions. Green Chem 2011, 13:1791.
50. Busto E., Gotor-Fernandez V., Gotor V. Hydrolases: catalytically promiscuous enzymes for non-conventional reactions in organic synthesis. Chem Soc Rev 2010, 39:4504-4523.
51. Wells A.S., Finch G.L., Michels P.C., Wong J.W. Use of enzymes in the manufacture of active pharmaceutical ingredients-a science and safety-based approach to ensure patient safety and drug quality. Org Process Res Dev 2012, 10.1021/op300153b.